The man who sent the price of lifesaving drug Daraprim (pyrimethamine) rocketing from $13.50 a tablet to $750 overnight has been ordered to repay $64.6m (£47m).
A pharma company formerly led by 'pharma bro' Martin Shkreli has settled a long-running lawsuit with the US federal government over massive price increases for an off-patent drug treatment
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh